KASMEJ

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

EndNote Style
Index
Original Article
Can disease activity be detected with serum biomarkers in ankylosing spondylitis?
Aims: The inflammation in Ankylosing Spondylitis (AS) patients is crucial regarding disease activity and progression. This study aims to evaluate the diagnostic significance of inflammatory markers in assessing disease activity in AS.
Methods: Seventy-six patients who met the criteria were assessed between January 2024 and June 2024. Inflammatory markers such as neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic inflammatory index (SII), and uric acid-to-HDL cholesterol ratio (UHR) were analyzed. Patients were divided into two groups as active and inactive AS according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score. ROC analysis was performed to investigate the diagnostic role of UHR and SII in indicating active disease.
Results: In the active disease group, parameters indicating inflammation, such as NLR (p=0.003), SII (p=0.001), and UHR (p=0.008), were found to be significantly elevated statistically. Positive statistically significant correlations were observed in correlation analysis between disease activity score and SII (r=0.36, p=0.006) and UHR (r=0.46, p=0.0001). ROC analysis revealed that UHR and SII have a high diagnostic role in indicating active disease.
Conclusion: NLR, SII, and UHR are considered to have a diagnostic role in indicating inflammation and active disease in AS patients.


1. Ramiro S, Nikiphorou E, Sepriano A, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82(1):19-34. doi:10.1136/ard-2022-223296
2. Wu J, Yan L, Chai K. Systemic Immune-inflammation Index is associated with disease activity in patients with ankylosing spondylitis. J Clin Lab Anal. 2021;35(9):e23964. doi:10.1002/jcla.23964
3. Taha SI, Samaan SF, Ibrahim RA, Moustafa NM, El-Sehsah EM, Youssef MK. Can complete blood count picture tell us more about the activity of rheumatological diseases? Clin Med Insights Arthritis Musculoskelet Disord. 2022;15:11795441221089182. doi:10.1177/11795441221089182
4. Deng J, Xu S, Gao X, Xu S, Shuai Z, Pan F. Red cell distribution width and mean platelet volume in patients with ankylosing spondylitis: a systematic review and meta-analysis. J Clin Rheumatol. 2021;27(7):292-297. doi:10.1097/RHU.0000000000001174
5. Gökmen F, Akbal A, Reşorlu H, et al. Neutrophil-lymphocyte ratio connected to treatment options and inflammation markers of ankylosing spondylitis. J Clin Lab Anal. 2015;29(4):294-298. doi:10.1002/jcla.21768
6. Zeb A, Khurshid S, Bano S, et al. The role of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as markers of disease activity in ankylosing spondylitis. Cureus. 2019;11(10):e6025. doi:10. 7759/cureus.6025
7. Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto’s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med. 2021;59(4):403-408. doi:10.2478/rjim- 2021-0023
8. Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019;65(1):9-15. doi: 10.1590/1806-9282.65.1.9
9. Kalfaoglu ME. Could serum uric acid to HDL cholesterol ratio predict sacroiliitis? PLoS One. 2023;18(10):e0289624. doi:10.1371/journal.pone. 0289624
10. Park B, Jung DH, Lee YJ. Predictive value of serum uric acid to HDL cholesterol ratio for incident ischemic heart disease in non-diabetic Koreans. Biomedicines. 2022;10(6):1422. doi:10.3390/biomedicines10061422
11. Cheng Y, Zhang H, Zheng H, et al. Association between serum uric acid/HDL-cholesterol ratio and chronic kidney disease: a cross-sectional study based on a health check-up population. BMJ Open. 2022;12(12): e066243. doi:10.1136/bmjopen-2022-066243
12. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994; 21(12):2286-2291.
13. Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi:10.1136/ard.2009.108233
14. Pekdiker M, Oğuzman H. The first involved joints and associated factors in patients with rheumatoid arthritis. Arch Rheumatol. 2024;39(2):274-284. doi:10.46497/ArchRheumatol.2024.10417
15. Cho J, Liang S, Lim SHH, Lateef A, Tay SH, Mak A. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio reflect disease activity and flares in patients with systemic lupus erythematosus-a prospective study. Joint Bone Spine. 2022;89(4):105342. doi:10.1016/j.jbspin.2022.105342
16. Yıldız F, Gökmen O. Haematologic indices and Disease Activity Index in primary Sjogren’s syndrome. Int J Clin Pract. 2021;75(3):e13992. doi: 10.1111/ijcp.13992
17. Kim DS, Shin D, Lee MS, et al. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 2016;43(3):305-310. doi:10. 1111/1346-8138.13061
18. Al-Osami MH, Awadh NI, Khalid KB, Awadh AI. Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with ankylosing spondylitis: a case-control study. Adv Rheumatol. 2020;60(1):13. doi:10.1186/s42358-020-0113-5
19. Khorrampazhouh N, Omranzadeh A, Fazeli B, et al. A Systematic review and meta-analysis of clinical studies on ankylosing spondylitis and neutrophil to lymphocyte ratio. Curr Rheumatol Rev. 2022;18(2):160-167. doi:10.2174/1573397117666210921114431
20. Hu B, Yang XR, Xu Y, et al. Systemic Immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-6222. doi:10.1158/1078-0432.CCR-14-0442
21. Kelesoglu S, Yilmaz Y, Elcık D, Kalay N. Systemic immune inflammation index: a novel predictor for coronary collateral circulation. Perfusion. 2022;37(6):605-612. doi:10.1177/02676591211014822
22. Erinc O, Yesilyurt S, Senat A. A comprehensive evaluation of hemogram-derived inflammatory indices in hashımoto thyroiditis and non-immunogenic hypothyroidism. Acta Endocrinol (Buchar). 2023;19(4): 435-440. doi:10.4183/aeb.2023.435
23. Başaran PÖ, Dogan M. The relationship between disease activity with pan-immune-inflammatory value and Systemic Immune-inflammation Index in rheumatoid arthritis. Medicine (Baltimore). 2024;103(9):e37230. doi:10.1097/MD.0000000000037230
24. Ozdemir A, Baran E, Kutu M, Celik S, Yılmaz M. Could systemic immune inflammation index be a new parameter for diagnosis and disease activity assessment in systemic lupus erythematosus? Int Urol Nephrol. 2023;55(1):211-216. doi:10.1007/s11255-022-03320-3
25. Zhen R, Wang S, Chen S. The relationship between UA/HDL and diabetic peripheral neuropathy: a cross-sectional analysis. Diabetes Metab Syndr Obes. 2024;17:969-980. doi:10.2147/DMSO.S447809
26. Xiong Q, Liu J, Xu Y. Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications. Int J Endocrinol. 2019;2019:9691345. doi:10. 1155/2019/9691345
27. Kjeldsen EW, Nordestgaard LT, Frikke-Schmidt R. HDL cholesterol and non-cardiovascular disease: a narrative review. Int J Mol Sci. 2021;22(9): 4547. doi:10.3390/ijms22094547
28. Aktas G, Yilmaz S, Kantarci DB, et al. Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med. 2023;135(5):519-523. doi:10.1080/00325481.2023.2214058
29. Zhao H, Qiu X, Li HZ, Cui JJ, Sun YY. Association between serum uric acid to HDL-cholesterol ratio and nonalcoholic fatty liver disease risk among Chinese adults. Biomed Environ Sci. 2023;36(1):1-9. doi:10.3967/bes2022.111
30. Chandrashekara S, Dhote SV, Anupama KR. The differential influence of immunological process of autoimmune disease on lipid metabolism: a study on RA and SLE. Indian J Clin Biochem. 2019;34(1):52-59. doi:10. 1007/s12291-017-0715-9
Volume 5, Issue 1, 2025
Page : 51-54
_Footer